Recorded Webinar from August 24, 2021. This virtual event sheds a light on the skepticism surrounding personalized medicine, which allows healthcare to be tailored to an individual’s unique genetic profile, providing for a more precise and tailored treatment. However, questions have been raised regarding this approach: if treatments are tailored to each individual’s genetic makeup, how can we test if it will actually work? How do we know it is safe?
Guest speakers from Certis Oncology and Hera BioLabs will address these questions and more during our live event, as they discuss how these standards are met using in vivo models meant to closely mirror the human response to tumors and other conditions.
CuttingConversation:Studies
0 Comments